Company profile: SpinChip Diagnostics
1.1 - Company Overview
Company description
- Provider of a point-of-care in vitro diagnostics platform with a fully automated analyzer (dual-axle centrifugal system, optical readout) and disposable microfluidic cartridges for rapid, accurate blood testing. Offers hs-cTnI heart attack results in 10 minutes, upcoming NT-pro-BNP assay, and co-development partnerships in human and veterinary diagnostics.
Products and services
- SpinChip Analyzer: A fully automated instrument that processes SpinChip cartridges via a dual axle centrifugal system with optical readout, analyzes blood samples near patients, reads results, and communicates findings
- SpinChip Platform: A state-of-the-art point-of-care diagnostic system combining the analyzer and disposable test cartridges to deliver rapid, accurate in vitro testing near patients across hospitals and decentralized medical settings
- High-Sensitivity Cardiac Troponin I (hs-cTnI) Test: A high-sensitivity assay for acute heart attacks that yields reliable results within 10 minutes from a droplet of blood when run on SpinChip cartridges
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to SpinChip Diagnostics
HealthFair
HQ: United States
Website
- Description: Provider of health and wellness services including awareness, education and preventive health tests via mobile health centers to help consumers improve and extend lives through early detection and prevention of disease.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full HealthFair company profile →
Diagnostic Products
HQ: United States
Website
- Description: Provider of in vitro diagnostics, including the IMMULITE(R) series of immunoassay systems, more than 75 immunoassays, and an expanding menu of essential specific allergens and allergy panels that are run just like other immunoassays.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Diagnostic Products company profile →
Zevacor
HQ: United States
Website
- Description: Provider of PET and SPECT radiopharmaceuticals, developing, manufacturing, and distributing compounds for PET and SPECT imaging to aid in the diagnosis, monitoring, and management of medical conditions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Zevacor company profile →
LumiraDx
HQ: United Kingdom
Website
- Description: Provider of a point-of-care diagnostic platform delivering lab-comparable performance via a portable instrument, microfluidic test strips, and digital connectivity, plus cloud-based reporting, analytics, and decision support. Offers COVID-19 antigen and antibody tests and microfluidic immunoassays including NT-proBNP, D-Dimer, and INR.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full LumiraDx company profile →
Biosynex
HQ: France
Website
- Description: Provider of rapid diagnostic solutions for health professionals, specializing in research, development and manufacturing of fast diagnosis tests on membrane support used in tropical and autoimmune diseases, emergency markers and infectious diseases; offerings include rapid diagnostic tests for prevention, screening and treatment, urinary infection test strips, and PathFast device performing up to six quantitative analyses in under 17 minutes without additional reagents.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biosynex company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for SpinChip Diagnostics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to SpinChip Diagnostics
2.2 - Growth funds investing in similar companies to SpinChip Diagnostics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for SpinChip Diagnostics
4.2 - Public trading comparable groups for SpinChip Diagnostics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →